ASICS
20.1.2023 10:24:37 CET | Business Wire | Press release
Today, ASICS reveals exercise can significantly improve cognitive function and advance mental performance. From boosting short-term memory to increasing concentration levels, exercise enhances brain power and could be the solution to helping us pass exams or excel at work.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230119005693/en/
Memory sport competitor, Ben Pridmore took part in the ASICS Mind Games study (Photo: Business Wire)
In a unique experiment, ASICS invited competitive gamers from around the world, specialising in mind games such as Chess and Esports and who rely on their cognitive function, to start an exercise programme. After four months of regular exercise, their minds were significantly sharpened and they performed at an even higher competitive level.
Participants’ international gaming rankings improved by an incredible 75% proving, yet again, the close interplay between our mind and body. The mind gamers’ cognitive function was boosted on average by 10%, with problem solving abilities improving by 9%, short-term memory increasing by 12% and processing speed and alertness improving by 10%. Group confidence levels increased by 44%, concentration improved by 33% and anxiety levels plummeted by 43%. The research shows exercise can be as effective at boosting brain function as learning a second language, daily reading, playing a new musical instrument or completing a puzzle every day.i
Professor Brendon Stubbs, a renowned researcher in movement and the mind, developed and led the experiment. Each gamer followed a training programme designed by runner turned international coach, Andrew Kastor. The programme included medium impact cardio and strength training and increased the gamers exercise levels to 150 minutes a week. Professor Stubbs measured the mental improvement of the participants based on their performance in their mind games, cognitive tests and wellbeing questionnaires over the course of their four-month research period.
Commenting on the results, Professor Brendon Stubbs said: “We all know that exercise is good for our mental and physical health but the impact on cognitive functioning has been less explored. We wanted to examine the effects of exercise on people who depend on their cognitive abilities - competitive mind gamers. Our results show significant improvements in their cognitive functioning, including concentration levels and problem-solving abilities.
“Exercise stimulates cell growth in the brain and rapidly increases blood flow to the hippocampus and prefrontal cortex, mechanisms that enable us to better retain memories, process information and problem solve quickly. If exercise can significantly increase the mental performance of professional mind gamers, imagine what it could do for the rest of us. From increasing focus when revising for an exam or improving alertness before a work presentation, exercise truly can enhance brain power.”
As well as showing that exercise improved the participants cognitive function and gaming capabilities, Professor Stubbs also found that the gamers’ mental wellbeing was significantly uplifted, with average State of Mind scores improving by 31%.ii The gamers’ average state of mind score at the start of the study was a below average 58 and at the end it was a high 76iii, demonstrating the significant impact exercise can also have on your mental wellbeing.
The study’s Head Coach, Andrew Kastor, who developed the gamers’ training programmes, stated: “These results are astonishing and speak to the power of exercise. Many of the gamers couldn’t jog for longer than a minute at the start of the study, so their training programmes had to be moderate. 150 minutes a week sounds a lot but when you break it down this could be 5 sets of 30 minutes. No matter your fitness levels, the mental benefits of exercise are accessible to all.”
Inspired by the experiment, a camera crew followed four competitive gamers as they took on regular exercise to improve their rankings on the international stage. The result was a new ground-breaking documentary ‘Mind Games – The Experiment’, narrated by the internationally acclaimed actor, and mental health campaigner, Stephen Fry. Now available to stream on Prime Video, the feature length film documents the journeys of four gamers – Kassa Korley, Ryoei Hirano, Ben Pridmore and Sherry Nhan – who specialise in Chess, Mahjong, Memory and Esports as they compete in professional tournaments around the world. Watch the documentary trailer here.
Gary Raucher, EVP, ASICS EMEA said: “Our founding philosophy is literally in our name, Anima Sana In Corpore Sano or a Sound Mind in a Sound Body. We have always encouraged utilising exercise for both physical and mental benefits, but this is the first time we have explored the true impact on cognitive functioning. Mind Games – The Experiment shows the power of exercise to sharpen the mind and we hope that after watching the documentary, everyone (regardless of their age, body type or fitness level) is inspired to move to help boost their brain.”
Mind Games - The Experiment is available to stream on Prime Video from 19th January 2023.
ENDS
Notes to Editors
The ASICS study ran from May – September 2022, with 77 gamers from 20 countries completing the experiment. All passed health screening questionnaires and completed consent forms before taking part.
For further information, images or to organise an interview with Professor Brendon Stubbs, Head Coach Andrew Kastor, or one of the gamers featured in the documentary, please contact Rory Cramsie at ASICSMindGames@golin.com
i Comparisons drawn from: https://journals.sagepub.com/doi/full/10.1177/09567976221092726 and https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6174231/ and https://www.frontiersin.org/articles/10.3389/fnagi.2021.706672/full#:~:text=Bilingualism%20has%20been%20linked%20to,cognitive%20enhancement%20in%20older%20adults
ii ASICS proprietary State of Mind score is a rating out of 100 made up of 10 emotional and cognitive metrics, including: composure, resilience, positivity, contentment, relaxation, confidence, alertness, calmness, focus and energy.
iii After four months the groups state of mind score increased into the top 10% globally.
Anima Sana In Corpore Sano, meaning “A Sound Mind in a Sound Body,” is an old Latin phrase from which ASICS is derived and the fundamental platform on which the brand still stands. The company was founded in 1949 by Kihachiro Onitsuka and is now a leading designer, developer and manufacturer of running shoes, as well as various sports footwear, apparel and accessories. For more information, visit www.asics.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230119005693/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
